Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

Amazon offers to help Biden with vaccine rollout

Published 01/21/2021, 12:28 PM
Updated 01/21/2021, 12:45 PM (NASDAQ:AMZN) has offered to use its operational muscle to help the Biden administration deliver the COVID-19 vaccine to more Americans, according to a letter addressed to President Biden, seen by Reuters.

In the letter, Dave Clark, the head of Amazon's worldwide consumer better, said, "We are prepared to leverage our operations, information technology, and communications capabilities and expertise to assist your administration's vaccination efforts."

The offer comes as Biden tries to make good on a pledge to delver 100 million doses of the vaccine in his first 100 days of office.

The effort has already been stymied as states like New York recently warn they already face the risk of running out of the vaccine.

At the same time, the outbreak shows no sign of slowing down.

COVID-19 has infected more than 24 million people in the U.S., with the death toll exceeding 400,000 since the pandemic started a year ago.

Amazon has had troubles of its own during the pandemic.

With more than 800,000 employees in the U.S., America's second-largest employer faced criticism from workers, who complained the tech giant was not doing enough to safeguard their health. More than 19,000 Amazon employees have contracted the virus as of September.

Amazon is planning its own employee vaccination plan in conjunction with a healthcare provider, the company also told the White House.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.